World's Best Scientists 2026 revealed!
Expert Review of Vaccines
H-index 30

Expert Review of Vaccines

1476-0584

Published by: Taylor & Francis

https://www.tandfonline.com/toc/ierv20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 74 64 98 22
Medicine 962 67 86 24

Additional Metrics

Number of Best Scientists*: 218
Documents by Best Scientists*: 230
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 112
SCIMAGO SJR: 1.255
Impact Factor: 4.8

Overview

Top Research Topics at Expert Review of Vaccines?

The scientific interests tackled in Expert Review of Vaccines are Immunology, Virology, Vaccination, Immune system and Antigen. It focuses on Immunology research which is adjacent to topics in Disease. The concepts on Virology presented in Expert Review of Vaccines can also apply to other research fields, including Antibody, Microbiology and Pandemic.

The studies on Vaccination discussed can also contribute to research in the domains of Clinical trial, Environmental health, Intensive care medicine, Public health and Pediatrics. Expert Review of Vaccines concentrated on Immune system research, specifically Immunotherapy, Acquired immune system and Innate immune system. Research on Immunotherapy featured in Expert Review of Vaccines is anchored on the understanding of topics like Cancer and Internal medicine.

The main emphasis of the journal is the research on Antigen, emphasizing the topic of Epitope. The Adjuvant works, particularly on Vaccine adjuvant are tackled in the journal.

  • Immunology (52.56%)
  • Virology (39.06%)
  • Vaccination (33.93%)

What are the most cited papers published in the journal?

  • CpG DNA as a vaccine adjuvant (567 citations)
  • Virus-like particles in vaccine development (502 citations)
  • Vaccines for fish in aquaculture (475 citations)

Research areas of the most cited articles at Expert Review of Vaccines:

The most cited articles are organized to address concerns in the fields of Immunology, Virology, Vaccination, Immune system and Antigen. Most of the works presented in the journal publications deal with Immunology but they intersect with the subject of Disease. The journal papers hold forums on Virology that merge themes from other disciplines such as Antibody, DNA vaccination, Microbiology and Clinical trial.

What topics the last edition of the journal is best known for?

  • Disease
  • Virus
  • Internal medicine

The previous edition focused in particular on these issues:

The journal primarily focuses on research topics in Vaccination, Virology, Coronavirus disease 2019 (COVID-19), Pandemic and Immunology. Topics in Vaccination explored in Expert Review of Vaccines were investigated in conjunction with research in Environmental health, Family medicine, Intensive care medicine, Disease and Public health. Issues in Virology were discussed, taking into consideration concepts from other disciplines like Epitope, Viral vector and Coronavirus.

The study of Pandemic encompasses disciplines such as Immunization, as well as fields such as Pediatrics, all of which overlap with one another. Immune system, Malaria, Immunogenicity, Malaria vaccine and Immunotherapy are among the concentrations of Immunology that garnered much attention in Expert Review of Vaccines. In addition to Immune system research, it aims to explore topics under Adjuvant, Antibody and Antigen.

The most cited articles from the last journal are:

  • Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies. (32 citations)
  • COVID-19 vaccine: where are we now and where should we go? (12 citations)
  • Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Expert Review of Vaccines (based on the number of publications) are:

  • Maarten J. Postma (22 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Sergio Rosales-Mendoza (17 papers) absent at the last edition,
  • Vasso Apostolopoulos (17 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • María L Avila-Aguero (16 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Umesh D. Parashar (16 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Review of Vaccines (based on the number of publications) are:

  • National Institutes of Health (65 papers) published 3 papers at the last edition, 1 less than at the previous edition,
  • Centers for Disease Control and Prevention (59 papers) published 9 papers at the last edition, 5 more than at the previous edition,
  • University of Oxford (38 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Sanofi Pasteur (35 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Pfizer (32 papers) published 8 papers at the last edition, 5 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.59% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.40% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.21% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.18% of all publications and 58.21% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?

    Sara Cooper;Sara Cooper;Heidi van Rooyen;Charles Shey Wiysonge;Charles Shey Wiysonge

    (2021)
    191 Citations
  • COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa

    (2022)
    115 Citations
  • DNA vaccines for SARS-CoV-2: toward third-generation vaccination era.

    Vivek P Chavda;Radhika Pandya;Vasso Apostolopoulos

    (2021)
    94 Citations
  • Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.

    Janet Sultana;Giampiero Mazzaglia;Nicoletta Luxi;Antonino Cancellieri

    (2020)
    89 Citations
  • Clinical development and approval of COVID-19 vaccines

    (2022)
    83 Citations
  • The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?

    Kamal Hossain;Majid Hassanzadeganroudsari;Vasso Apostolopoulos

    (2021)
    77 Citations
  • Army Liposome Formulation (ALF) family of vaccine adjuvants

    Carl R Alving;Kristina K Peachman;Kristina K Peachman;Gary R Matyas;Mangala Rao

    (2020)
    68 Citations
  • Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.

    Patrick E Duffy

    (2021)
    64 Citations
  • COVID-19 vaccines: concerns beyond protective efficacy and safety.

    Chih-Cheng Lai;I-Tzu Chen;Chien-Ming Chao;Ping-Ing Lee

    (2021)
    64 Citations
  • Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic

    (2022)
    60 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical career options beyond traditional paths, several online programs offer flexible and efficient routes. Professionals aiming to specialize in psychiatric nursing can benefit from exploring the shortest pmhnp program, which allows for quicker certification as a Psychiatric Mental Health Nurse Practitioner.

Nurses wishing to advance their practice can look into the fastest post master's fnp certificate, providing a streamlined path to becoming a Family Nurse Practitioner through convenient online courses.

Those interested in nutrition and wellness can consider an online nutrition degree, which opens career opportunities in dietetics, health coaching, and community health education.

Additionally, registered nurses looking to enhance their credentials frequently pursue an rn to bsn program. These online degrees provide a foundation for leadership roles, higher earning potential, and better patient care practices.

Best Scientists Contributing to This Journal

Recently Published Articles